Vietnam-based Gene Solutions is preparing to go public in Hong Kong to raise about $100 million, Bloomberg reported Monday, citing the diagnostic startup's chief executive.
The initial public offering is targeted for the second to third quarter of 2027, with a planned valuation of around $800 million, the report said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)